Correction to: Determination of the absolute oral bioavailability of niraparib by simultaneous administration of aC-microtracer and therapeutic dose in cancer patients
Files
Publication date
2018-01
Authors
van Andel, L
Rosing, H.
Zhang, Z
Hughes, L.
Kansra, V
Sanghvi, M
Tibben, M.
Gebretensae, A.
Schellens, Johannes
Beijnen, Jos
Editors
Advisors
Supervisors
Document Type
Article
Metadata
Show full item recordCollections
License
Abstract
The article ''Determination of the absolute oral bioavailability of niraparib by simultaneous administration of a14C-microtracer and therapeutic dose in cancer patients'', written by L. van Andel, H. Rosing, Z. Zhang, L. Hughes, V. Kansra, M. Sanghvi, M. M. Tibben, A. Gebretensae, J. H. M. Schellens and J. H. Beijnen, was originally published electronically on the publisher's internet portal (currently SpringerLink) on 17th October 2017 without open access.
Keywords
Published Erratum, SDG 3 - Good Health and Well-being
Citation
van Andel, L, Rosing, H, Zhang, Z, Hughes, L, Kansra, V, Sanghvi, M, Tibben, M, Gebretensae, A, Schellens, J H M & Beijnen, J H 2018, 'Correction to : Determination of the absolute oral bioavailability of niraparib by simultaneous administration of aC-microtracer and therapeutic dose in cancer patients', Cancer Chemotherapy and Pharmacology, vol. 81, no. 1, pp. 47. https://doi.org/10.1007/s00280-017-3474-7